Mirko Manetti Selected Research

Mirko Manetti Research Topics

Disease

23	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 01/2006
10	Fibrosis (Cirrhosis) 03/2022 - 10/2007
8	Inflammation (Inflammations) 01/2020 - 01/2009
5	Rheumatoid Arthritis 10/2017 - 04/2007
4	Osteoarthritis 06/2019 - 04/2007
3	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 09/2014
3	Synovitis 01/2021 - 10/2017
3	Joint Diseases (Joint Disease) 06/2019 - 08/2012
3	Hemophilia A (Haemophilia) 06/2019 - 02/2016
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 09/2014
3	Ischemia 07/2011 - 06/2010
2	Pain (Aches) 05/2022 - 01/2021
2	Keratoconus 03/2022 - 04/2017
2	digital ulcers 03/2022 - 04/2015
2	Arthritis (Polyarthritis) 01/2021 - 06/2019
2	Necrosis 01/2021 - 11/2010
2	Neoplasms (Cancer) 04/2020 - 01/2017
2	Reperfusion Injury 01/2018 - 01/2013
2	Hypoxia (Hypoxemia) 01/2018 - 04/2007
2	Hemophilia B (Haemophilia B) 01/2018 - 02/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2011 - 01/2009
2	Pulmonary Arterial Hypertension 01/2011 - 06/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2022
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Lymphedema (Milroy Disease) 05/2022
1	Keratoconus 2 03/2022
1	Ulcer 01/2022
1	Acidosis 10/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Fatigue 01/2021
1	Seroma 10/2020
1	Seminoma 04/2020
1	Sjogren's Syndrome (Sjogren Syndrome) 05/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Hemorrhage 01/2018
1	Edema (Dropsy) 01/2018

Drug/Important Bio-Agent (IBA)

5	Urokinase Plasminogen Activator ReceptorsIBA 10/2021 - 12/2006
5	CytokinesIBA 01/2020 - 10/2007
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2007
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2019 - 01/2009
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2016 - 04/2007
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 02/2011 - 01/2009
2	Messenger RNA (mRNA)IBA 10/2022 - 04/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 06/2013
2	Vascular Endothelial Growth Factor CIBA 04/2016 - 03/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 08/2013
2	CollagenIBA 09/2014 - 01/2010
2	Interleukin-33IBA 10/2011 - 03/2010
1	Carrier Proteins (Binding Protein)IBA 10/2022
1	RNA Splicing FactorsIBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Arginine (L-Arginine)FDA Link 10/2022
1	Serine (L-Serine)FDA Link 10/2022
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2022
1	Sirtuin 3IBA 03/2022
1	Sirtuin 1IBA 03/2022
1	treprostinil FDA Link 01/2022
1	Rheumatoid FactorIBA 01/2021
1	Anti-Citrullinated Protein AntibodiesIBA 01/2021
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 01/2021
1	GalactosamineIBA 04/2020
1	polysialic acidIBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2020
1	Hematoxylin (Haematoxylon)IBA 04/2020
1	Sialic AcidsIBA 04/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	LipidsIBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2019
1	Caspase 3 (Caspase-3)IBA 06/2019
1	Sodium Glutamate (Accent)IBA 05/2019
1	streptococcal polysaccharide type III group BIBA 01/2019
1	Chemokine CCL24IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Protein SIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Thrombin FDA Link 01/2018
1	AnticoagulantsIBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2018
1	Type 2 Angiotensin ReceptorIBA 10/2017
1	Riboflavin (Vitamin B2)FDA LinkGeneric 04/2017
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2017

Therapy/Procedure

5	Therapeutics 05/2022 - 06/2010
2	Corneal Transplantation (Keratoplasty) 03/2022 - 04/2017
1	Penetrating Keratoplasty 03/2022
1	Activities of Daily Living (ADL) 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2020
1	Mastectomy (Mammectomy) 10/2020
1	Corneal Cross-Linking 04/2017
1	Transplantation 01/2017